More than 1,275,000 people are living with SCI in the USA (and almost 3 million in the other westernized countries of the world). The National Spinal Cord Injury Statistical Center reports 40 new cases per million of the population per year. More than 80% of these individuals exhibit at least some degree of bladder dysfunction. Additionally, there are a number of other significant diseases or conditions that cause paralysis and can result in incontinence not the least of which are people who have suffered a stroke. The new severe incontinence treatment technology being presented by Precision Medical Devices (PMD), which can be implanted in a 15 (to 20)-minute same day surgical procedure is designed, and expected to optimally treat the severer cases of urinary incontinence (UI). In fact, the current most utilized method of dealing with spinal cord injury-caused urinary incontinence has been the use of indwelling, or self, catheterization, which heightens the risk of causing bladder cancer by three-fold not to mention a greatly increased prevalence of urinary tract infections (UTIs) along with all the other associated adverse events that occur as a result of the UTIs. Given the foregoing, it is expected that PMD’s new bionic, telemetrically-controlled urethral valve will virtually eliminate the problems experienced by anyone currently suffering from severe UI, and there is even the promise that the same technology will be able to treat severe fecal incontinence (FI), as well, with SCI and paralyzed patients obtaining great relief, especially if the urinary retention is properly treated, including the promise of having a UI (or FI) control device that could be activated using voice control systems.